Vaccine Clinical Trials
Vaccine clinical trials assess the safety and efficacy of a new vaccine medicine as well as its ability to provoke an immune response. Vaccine clinical trials may also assess how well the product does with existing healthcare delivery systems, such as national immunization programs. Vaccine clinical trials are a very important source of data for decisions around vaccine development. A well-experienced contract research organization should always seek to ensure that all vaccine clinical trials adhere to the highest scientific and ethical standards and are designed and run in a way that provides accurate and viable data on the candidate. Contract research organizations doing vaccine trials should also ensure that the trial is of a quality that will be accepted by regulatory agencies.
Unfortunately, even though most vaccine development pharmaceutical companies are located in the United States, there are only a few, perhaps only one or two, contract research organizations that can cater to the needs of US-based vaccine development by conducting research with the United States. http://wcct.com/influenza-clinical-research-2/Typically, clinical trials are carried out in phases, each focusing on some overlapping and some new research questions and with each phase giving developers more knowledge and information about the next steps of testing and development. There are 4 phases of clinical research: Phase I, also called Early Phase, which is when the vaccine is being tested for the very first time in healthy adults for safety, dosage, and possible side effects. https://www.youtube.com/watch?v=5AVmRYYqAggPhase II which is done in a bigger group is testing for how effective the vaccine is as well as if there are other methods of delivery. https://www.youtube.com/watch?v=3wfT2Q-Zc-0Phase III is after there is even more information and even less of a risk, the vaccine is tested on adults and children to compare the vaccine to an already approved alternative of the vaccine. https://www.youtube.com/watch?v=SCwSolobA0sAnd finally Phase IV which is the final stage in which the vaccine has already been approved by the FDA and data collecting is then used for research and collecting information on the long term use of said vaccine.
There is a new model for influenza clinical research, called the Influenza Challenge Model or (Human Challenge Model), in which a group of volunteers are administered an H1N1 virus, and observed as flu symptoms progress. Then, they are given a treatment to cure the symptoms. Being able to observe and analyze the lifecycle of the virus within human subjects has produced valuable results and insight into developing viable vaccines for the illness, to combat both common cases and global outbreaks alike. There are only a few locations where such a model can be implemented throughout the world, and, to my knowledge, only one within the United States.Pharmaceutical research tends to be an iterative rather than a linear process. Knowledge gained through vaccine clinical trials results often informs further research on the product, until it is deemed ready to go on to the next phase or is rejected as a candidate.I really love to study science but I'm also attracted to other interests especially biology and working out at the health club. The research I am doing these days is centered mostly on medical discoveries and it's my objective to explain these different procedures. I have a deep belief in the power of clinical research and believe that more people should look into ways to actively participate. These explorations through the scientific landscape at this time has advanced me to a considerable appreciation of the content. I think it takes a specific kind of human being who can respond to a few of the more penetrating queries that certainly crop up in this process. I'm not sure if I'm imminently qualified it's my desire that these types of columns are successful in some way.
Unfortunately, even though most vaccine development pharmaceutical companies are located in the United States, there are only a few, perhaps only one or two, contract research organizations that can cater to the needs of US-based vaccine development by conducting research with the United States. http://wcct.com/influenza-clinical-research-2/Typically, clinical trials are carried out in phases, each focusing on some overlapping and some new research questions and with each phase giving developers more knowledge and information about the next steps of testing and development. There are 4 phases of clinical research: Phase I, also called Early Phase, which is when the vaccine is being tested for the very first time in healthy adults for safety, dosage, and possible side effects. https://www.youtube.com/watch?v=5AVmRYYqAggPhase II which is done in a bigger group is testing for how effective the vaccine is as well as if there are other methods of delivery. https://www.youtube.com/watch?v=3wfT2Q-Zc-0Phase III is after there is even more information and even less of a risk, the vaccine is tested on adults and children to compare the vaccine to an already approved alternative of the vaccine. https://www.youtube.com/watch?v=SCwSolobA0sAnd finally Phase IV which is the final stage in which the vaccine has already been approved by the FDA and data collecting is then used for research and collecting information on the long term use of said vaccine.
There is a new model for influenza clinical research, called the Influenza Challenge Model or (Human Challenge Model), in which a group of volunteers are administered an H1N1 virus, and observed as flu symptoms progress. Then, they are given a treatment to cure the symptoms. Being able to observe and analyze the lifecycle of the virus within human subjects has produced valuable results and insight into developing viable vaccines for the illness, to combat both common cases and global outbreaks alike. There are only a few locations where such a model can be implemented throughout the world, and, to my knowledge, only one within the United States.Pharmaceutical research tends to be an iterative rather than a linear process. Knowledge gained through vaccine clinical trials results often informs further research on the product, until it is deemed ready to go on to the next phase or is rejected as a candidate.I really love to study science but I'm also attracted to other interests especially biology and working out at the health club. The research I am doing these days is centered mostly on medical discoveries and it's my objective to explain these different procedures. I have a deep belief in the power of clinical research and believe that more people should look into ways to actively participate. These explorations through the scientific landscape at this time has advanced me to a considerable appreciation of the content. I think it takes a specific kind of human being who can respond to a few of the more penetrating queries that certainly crop up in this process. I'm not sure if I'm imminently qualified it's my desire that these types of columns are successful in some way.
Replies